Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GRAP2 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-16 |
mRNA | LAPTM4B | GDSC1000 | pan-cancer | AAC | 0.44 | 4e-16 |
mRNA | HBB | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-16 |
mRNA | HMBS | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-16 |
mRNA | AHSP | GDSC1000 | pan-cancer | AAC | 0.28 | 5e-16 |
mRNA | MATK | CTRPv2 | pan-cancer | AAC | 0.3 | 6e-16 |
mRNA | RHCE | GDSC1000 | pan-cancer | AAC | 0.28 | 6e-16 |
mRNA | STON2 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-16 |
mRNA | KEL | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-15 |
mRNA | SOCS2 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-15 |